Abstract
The nuclear factor-kappa B (NFκB) family of transcription factors has emerged as a signaling pathway that figures prominently in a cell’s initial response to a plethora of inflammatory stimuli. Modified lipids, oxidative stress, bacterial endotoxins, growth factors and cytokines, such as platelet-derived growth factor (PDGF) and interleukin-1 (IL-1), are among the stimuli that free NFκB dimers from their cytosolic inhibitor proteins leading to nuclear translocation of NFκB and transactivation of target genes (1–3). The smooth muscle cells (SMC) of the vasculature express components of this pathway and are activated by these stimuli, promoting dysregulation of gene expression by cells within the atherosclerotic vessel. Indeed, NFκB proteins have been localized within the nuclei of vascular SMC at sites of human atherosclerotic lesions, suggesting a role for NFκB in activation of this cell type in vivo (4–6). NFκB participates in dysregulated gene expression not only by SMC but also by endothelial cells and macrophages, prominent cell types within atherosclerotic lesions, thus much attention has focused on the workings of this signaling pathway within vascular cells and its role in atherogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Siebenlist, U., Franzoso, G., and Brown, K. (1994) Structure, Regulation and Function of NF-kB. Annu. Rev. Cell Biol., 10, 405–455.
Baeuerle, P. A. and Baltimore, D. (1996) NF-kB: Ten years after. Cell, 87, 13–20.
May, M. J. and Ghosh, S. (1998) Signal transduction through NF-kB. Immunology Today, 19(2), 80–88.
Bourcier, T., Sukhova, G., and Libby, P. (1997) The nuclear factor-kB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J. Biol. Chem., 272(25), 15,817–15,824.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., and Neumeier, D. (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest., 97, 1715–1722.
Bellas, R. E., Lee, J. S., and Sonenshein, G. E. (1995) Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J. Clin. Invest., 96, 2521–2527.
Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475–1489.
Lin, R., Gewert, D., and Hiscott, J. (1995) Differential transcriptional activation in vitro by NF-kappa B/Rel proteins. J. Biol. Chem., 270, 3123–3131.
Lehming, N., Thanos, D., Brickman, J., Ma, J., Maniatis, T., and Ptashne, M. (1994) An HMG-like protein that can switch a transcriptional activator to a repressor. Nature, 371, 175–179.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Bourcier, T. (1999). Electromobility Shift Analysis (EMSA) Applied to the Study of NF-kappa B Binding Interactions in Vascular Smooth Muscle Cells. In: Baker, A.H. (eds) Vascular Disease. Methods in Molecular Medicine™, vol 30. Humana Press. https://doi.org/10.1385/1-59259-247-3:159
Download citation
DOI: https://doi.org/10.1385/1-59259-247-3:159
Publisher Name: Humana Press
Print ISBN: 978-0-89603-731-1
Online ISBN: 978-1-59259-247-0
eBook Packages: Springer Protocols